Anti-aquaporin-4 Antibody-positive Definite Neuromyelitis Optica in a Patient With Thymectomy for Myasthenia Gravis

BACKGROUND:Since serum anti-aquaporin-4 (AQP4) antibody/neuromyelitis optica (NMO)-IgG has been detected as a specific biomarker for NMO), new diagnostic criteria have been proposed. Recently, a rare coexistence of NMO and myasthenia gravis (MG) has been documented. Here, we provide further evidence...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Neurologist (Baltimore, Md.) Md.), 2012-03, Vol.18 (2), p.76-79
Hauptverfasser:	Ogaki, Kotaro, Hirayama, Takashi, Chijiiwa, Karina, Fukae, Jiro, Furuya, Tsuyoshi, Noda, Kazuyuki, Fujishima, Kenji, Hattori, Nobutaka, Takahashi, Toshiyuki, Okuma, Yasuyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Adult Aquaporin 4 - immunology Autoantibodies - biosynthesis Autoantibodies - blood Female Humans Middle Aged Myasthenia Gravis - complications Myasthenia Gravis - immunology Myasthenia Gravis - surgery Neuromyelitis Optica - complications Neuromyelitis Optica - drug therapy Neuromyelitis Optica - immunology Thymectomy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!